Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease118
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review83
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath66
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications48
Transthyretin mutagenesis: impact on amyloidogenesis and disease39
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application33
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology32
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation31
Evaluating thyroid function in pregnant women31
Cardiovascular disease lipids and lipoproteins biomarker standardization29
Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure28
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker28
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology26
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration25
Challenges of insulin-like growth factor-1 testing23
Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications23
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1921
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases21
Using a systematic approach to strategic innovation in laboratory medicine to bring about change21
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future20
Emerging applications of machine learning in genomic medicine and healthcare19
Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections19
The intersection of the laboratory and transgender care18
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?17
Revisiting approaches to and considerations for urinalysis and urine culture reflexive testing17
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis16
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders15
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor14
Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review14
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?13
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review13
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)13
DNA/RNA-based electrochemical nanobiosensors for early detection of cancers12
Point of care blood glucose devices in the hospital setting12
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer12
Establishing, evaluating and monitoring analytical quality in the traceability era12
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization12
From fructose to the future: liver disease biomarkers and their prognostic value in acute liver failure12
0.038372993469238